335 results on '"Allison, Derek B."'
Search Results
2. Precision Medicine in Cytopathology
3. Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis
4. Spatial metabolomics reveals glycogen as an actionable target for pulmonary fibrosis
5. TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly specific and sensitive for a breast primary?
6. Using Artificial Intelligence to Identify Tumor Microenvironment Heterogeneity in Non–Small Cell Lung Cancers
7. A kinome-wide CRISPR screen identifies CK1α as a target to overcome enzalutamide resistance of prostate cancer
8. Urinary Tract Exfoliative Cytology and Biopsy Specimens: Other Urothelial Tract Neoplasms
9. Urinary Tract Exfoliative Cytology and Biopsy Specimens: High-Grade Urothelial Carcinoma
10. Urinary Tract Exfoliative Cytology and Biopsy Specimens: Nonneoplastic Findings
11. Urinary Tract Exfoliative Cytology and Biopsy Specimens: Low-Grade Urothelial Neoplasms
12. High-Grade Urothelial Carcinoma (HGUC)
13. PD30-03 PREDICTING RESPONSE TO INTRAVESICAL BCG IN HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER USING AN ARTIFICIAL INTELLIGENCE-POWERED PATHOLOGY ASSAY: DEVELOPMENT AND VALIDATION IN AN INTERNATIONAL 12 CENTER COHORT
14. PD27-12 DEVELOPMENT AND VALIDATION OF GENERALIZABLE INTERPRETABLE AI BIOMARKERS TO PREDICT CLINICAL OUTCOMES IN BCG-TREATED PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER
15. Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production
16. An Update on the Management of Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN)
17. Urinary Tract Exfoliative Cytology and Biopsy Specimens: Nonneoplastic Findings
18. Urinary Tract Exfoliative Cytology and Biopsy Specimens: Low-Grade Urothelial Neoplasms
19. Urinary Tract Exfoliative Cytology and Biopsy Specimens: High-Grade Urothelial Carcinoma
20. High-dimensionality reduction clustering of complex carbohydrates to study lung cancer metabolic heterogeneity
21. Urinary Tract Exfoliative Cytology and Biopsy Specimens: Other Urothelial Tract Neoplasms
22. Abstract B020: M1 macrophage engineered vesicles as ovarian cancer treatment in a mouse xenograft model
23. Dysregulation of mitochondrial function by PLK1-mediated PDHA1 phosphorylation promotes Cr(VI)-associated lung cancer progression
24. Case report: Enfortumab vedotin induced refractory DKA and multi organ failure – a rare fatal adverse event
25. Pathology Residency Program Special Expertise Tracks Meet the Needs of an Evolving Field
26. Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD.
27. Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling
28. Urinary tract cytology showing variant morphology and divergent differentiation
29. Locally advanced solitary fibrous tumour of the prostate
30. Molecular Tumor Board–Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical Trial
31. Liver Cytology
32. Pulmonary Cytology
33. Variability among observers utilizing the CellSolutions BestCyte Cell Sorter imaging system for the assessment of urinary tract cytology specimens
34. Urinary tract cytology showing variant morphology and divergent differentiation.
35. Primary mediastinal seminoma presenting with paraneoplastic anti-Hu encephalitis: a case report and literature review
36. The Addition of a Cell Block Reduces Indeterminate Diagnoses and Improves the Diagnostic Accuracy in Urine Cytology
37. Single-cell analysis characterizes PLK1 as a promoter of immunosuppressive tumor microenvironment in LUAD
38. Association of CD47 Expression with Clinicopathologic Characteristics and Survival Outcomes in Muscle Invasive Bladder Cancer
39. Pediatric Rhabdomyosarcomas of the Genitourinary Tract
40. A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer
41. Abstract 4840: Dysregulation of mitochondrial function by PLK1-mediated PDHA1 phosphorylation promotes Cr(VI)-associated lung cancer progression
42. Abstract 4992: Taxol-elevated PLK1 overcomes BETi-resistant in prostate cancer via triggering phosphorylation-dependent degradation of BRD4
43. Abstract 3673: Plk1 phosphorylation of PHGDH to regulate serine metabolism
44. Supplemental Figure 1 from In Situ Analysis of N-Linked Glycans as Potential Biomarkers of Clinical Course in Human Prostate Cancer
45. Data from In Situ Analysis of N-Linked Glycans as Potential Biomarkers of Clinical Course in Human Prostate Cancer
46. Supplemental Figure 4 from In Situ Analysis of N-Linked Glycans as Potential Biomarkers of Clinical Course in Human Prostate Cancer
47. Supplemental Figure 3 from In Situ Analysis of N-Linked Glycans as Potential Biomarkers of Clinical Course in Human Prostate Cancer
48. Supplemental Figure Legends from In Situ Analysis of N-Linked Glycans as Potential Biomarkers of Clinical Course in Human Prostate Cancer
49. Supplemental Figure 5 from In Situ Analysis of N-Linked Glycans as Potential Biomarkers of Clinical Course in Human Prostate Cancer
50. Supplemental Figure 2 from In Situ Analysis of N-Linked Glycans as Potential Biomarkers of Clinical Course in Human Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.